Irritable bowel syndrome prevalence in patients with familial mediterranean fever

Adem Kucuk, Murat Biyik, Yalcin Solak, Ramazan Ucar, Ilker Polat, Fatih Pektas, Gokhan Gungor, Abduzhappar Gaipov, Sinan Bagcaci, Huseyin Ataseven, Recep Tunc

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Patients with Familial Mediterranean Fever (FMF) and Irritable bowel syndrome (IBS) share some clinical features including abdominal pain, constipation and diarrhea. Furthermore, some patients with FMF do not have typical abdominal pain and fever attacks rather they have nonspecific symptoms. This makes the diagnosis of FMF harder and lead to a delay in starting the colchicine treatment. Both diseases lack specific diagnostic tests. We aimed to determine the prevalence of IBS in patients with established diagnosis of FMF. Materials and methods: FMF patients who had been diagnosed according to Tel-Hashomer criteria in Rheumatology clinic of a university hospital were included in the study between January 2011 and December 2011. 10 point IBS questionnaire according to Rome III criteria was used to determine the presence of IBS. Patients with recent FMF attack and abdominal pain from other reasons were excluded. Results: One-hundred and thirteen patients (67 females and 46 males) with an established diagnosis of FMF were included in the study. The mean duration of FMF was 6.4 ± 6.7 years. IBS prevalence based on Roma III criteria was 40.7% (n=46). IBS prevalence was 30.4% (n=14) in male patients and 47.8 % (n=32) in female patients (p=0.06). In female patients IBS subtypes were as follows; IBS mixed type (IBS-M) 37% (n=12), IBS diarrhea predominant (IBS-D) 22% (n=7), IBS unsubtyped (IBS-U) 22% (n=7), and IBS constipation predominant (IBS-C) 19% (n=6), whereas in male patients, IBS-M 57% (n=8), IBS-C 29% (n=4), IBS-D 7% (n=1) and IBS-U 7% (n=1). The most common subtype of IBS was IBS-M in both sexes. Conclusion: IBS is frequent in FMF patients when Rome III criteria are used for diagnosis. The question to be answered is whether increased frequency or merely the failure of Rome III criteria to differentiate IBS in such patient groups with abdominal discomfort.

Original languageEnglish (US)
Pages (from-to)841-846
Number of pages6
JournalActa Medica Mediterranea
Volume31
Issue number4
StatePublished - Jan 1 2015

Fingerprint

Familial Mediterranean Fever
Irritable Bowel Syndrome
Abdominal Pain
Constipation
Diarrhea
Roma

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kucuk, A., Biyik, M., Solak, Y., Ucar, R., Polat, I., Pektas, F., ... Tunc, R. (2015). Irritable bowel syndrome prevalence in patients with familial mediterranean fever. Acta Medica Mediterranea, 31(4), 841-846.

Irritable bowel syndrome prevalence in patients with familial mediterranean fever. / Kucuk, Adem; Biyik, Murat; Solak, Yalcin; Ucar, Ramazan; Polat, Ilker; Pektas, Fatih; Gungor, Gokhan; Gaipov, Abduzhappar; Bagcaci, Sinan; Ataseven, Huseyin; Tunc, Recep.

In: Acta Medica Mediterranea, Vol. 31, No. 4, 01.01.2015, p. 841-846.

Research output: Contribution to journalArticle

Kucuk, A, Biyik, M, Solak, Y, Ucar, R, Polat, I, Pektas, F, Gungor, G, Gaipov, A, Bagcaci, S, Ataseven, H & Tunc, R 2015, 'Irritable bowel syndrome prevalence in patients with familial mediterranean fever', Acta Medica Mediterranea, vol. 31, no. 4, pp. 841-846.
Kucuk A, Biyik M, Solak Y, Ucar R, Polat I, Pektas F et al. Irritable bowel syndrome prevalence in patients with familial mediterranean fever. Acta Medica Mediterranea. 2015 Jan 1;31(4):841-846.
Kucuk, Adem ; Biyik, Murat ; Solak, Yalcin ; Ucar, Ramazan ; Polat, Ilker ; Pektas, Fatih ; Gungor, Gokhan ; Gaipov, Abduzhappar ; Bagcaci, Sinan ; Ataseven, Huseyin ; Tunc, Recep. / Irritable bowel syndrome prevalence in patients with familial mediterranean fever. In: Acta Medica Mediterranea. 2015 ; Vol. 31, No. 4. pp. 841-846.
@article{c7c4b2dcac404c2ba95ba7e37d8fbdc1,
title = "Irritable bowel syndrome prevalence in patients with familial mediterranean fever",
abstract = "Introduction: Patients with Familial Mediterranean Fever (FMF) and Irritable bowel syndrome (IBS) share some clinical features including abdominal pain, constipation and diarrhea. Furthermore, some patients with FMF do not have typical abdominal pain and fever attacks rather they have nonspecific symptoms. This makes the diagnosis of FMF harder and lead to a delay in starting the colchicine treatment. Both diseases lack specific diagnostic tests. We aimed to determine the prevalence of IBS in patients with established diagnosis of FMF. Materials and methods: FMF patients who had been diagnosed according to Tel-Hashomer criteria in Rheumatology clinic of a university hospital were included in the study between January 2011 and December 2011. 10 point IBS questionnaire according to Rome III criteria was used to determine the presence of IBS. Patients with recent FMF attack and abdominal pain from other reasons were excluded. Results: One-hundred and thirteen patients (67 females and 46 males) with an established diagnosis of FMF were included in the study. The mean duration of FMF was 6.4 ± 6.7 years. IBS prevalence based on Roma III criteria was 40.7{\%} (n=46). IBS prevalence was 30.4{\%} (n=14) in male patients and 47.8 {\%} (n=32) in female patients (p=0.06). In female patients IBS subtypes were as follows; IBS mixed type (IBS-M) 37{\%} (n=12), IBS diarrhea predominant (IBS-D) 22{\%} (n=7), IBS unsubtyped (IBS-U) 22{\%} (n=7), and IBS constipation predominant (IBS-C) 19{\%} (n=6), whereas in male patients, IBS-M 57{\%} (n=8), IBS-C 29{\%} (n=4), IBS-D 7{\%} (n=1) and IBS-U 7{\%} (n=1). The most common subtype of IBS was IBS-M in both sexes. Conclusion: IBS is frequent in FMF patients when Rome III criteria are used for diagnosis. The question to be answered is whether increased frequency or merely the failure of Rome III criteria to differentiate IBS in such patient groups with abdominal discomfort.",
author = "Adem Kucuk and Murat Biyik and Yalcin Solak and Ramazan Ucar and Ilker Polat and Fatih Pektas and Gokhan Gungor and Abduzhappar Gaipov and Sinan Bagcaci and Huseyin Ataseven and Recep Tunc",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "31",
pages = "841--846",
journal = "Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",
issn = "1520-4391",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Irritable bowel syndrome prevalence in patients with familial mediterranean fever

AU - Kucuk, Adem

AU - Biyik, Murat

AU - Solak, Yalcin

AU - Ucar, Ramazan

AU - Polat, Ilker

AU - Pektas, Fatih

AU - Gungor, Gokhan

AU - Gaipov, Abduzhappar

AU - Bagcaci, Sinan

AU - Ataseven, Huseyin

AU - Tunc, Recep

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction: Patients with Familial Mediterranean Fever (FMF) and Irritable bowel syndrome (IBS) share some clinical features including abdominal pain, constipation and diarrhea. Furthermore, some patients with FMF do not have typical abdominal pain and fever attacks rather they have nonspecific symptoms. This makes the diagnosis of FMF harder and lead to a delay in starting the colchicine treatment. Both diseases lack specific diagnostic tests. We aimed to determine the prevalence of IBS in patients with established diagnosis of FMF. Materials and methods: FMF patients who had been diagnosed according to Tel-Hashomer criteria in Rheumatology clinic of a university hospital were included in the study between January 2011 and December 2011. 10 point IBS questionnaire according to Rome III criteria was used to determine the presence of IBS. Patients with recent FMF attack and abdominal pain from other reasons were excluded. Results: One-hundred and thirteen patients (67 females and 46 males) with an established diagnosis of FMF were included in the study. The mean duration of FMF was 6.4 ± 6.7 years. IBS prevalence based on Roma III criteria was 40.7% (n=46). IBS prevalence was 30.4% (n=14) in male patients and 47.8 % (n=32) in female patients (p=0.06). In female patients IBS subtypes were as follows; IBS mixed type (IBS-M) 37% (n=12), IBS diarrhea predominant (IBS-D) 22% (n=7), IBS unsubtyped (IBS-U) 22% (n=7), and IBS constipation predominant (IBS-C) 19% (n=6), whereas in male patients, IBS-M 57% (n=8), IBS-C 29% (n=4), IBS-D 7% (n=1) and IBS-U 7% (n=1). The most common subtype of IBS was IBS-M in both sexes. Conclusion: IBS is frequent in FMF patients when Rome III criteria are used for diagnosis. The question to be answered is whether increased frequency or merely the failure of Rome III criteria to differentiate IBS in such patient groups with abdominal discomfort.

AB - Introduction: Patients with Familial Mediterranean Fever (FMF) and Irritable bowel syndrome (IBS) share some clinical features including abdominal pain, constipation and diarrhea. Furthermore, some patients with FMF do not have typical abdominal pain and fever attacks rather they have nonspecific symptoms. This makes the diagnosis of FMF harder and lead to a delay in starting the colchicine treatment. Both diseases lack specific diagnostic tests. We aimed to determine the prevalence of IBS in patients with established diagnosis of FMF. Materials and methods: FMF patients who had been diagnosed according to Tel-Hashomer criteria in Rheumatology clinic of a university hospital were included in the study between January 2011 and December 2011. 10 point IBS questionnaire according to Rome III criteria was used to determine the presence of IBS. Patients with recent FMF attack and abdominal pain from other reasons were excluded. Results: One-hundred and thirteen patients (67 females and 46 males) with an established diagnosis of FMF were included in the study. The mean duration of FMF was 6.4 ± 6.7 years. IBS prevalence based on Roma III criteria was 40.7% (n=46). IBS prevalence was 30.4% (n=14) in male patients and 47.8 % (n=32) in female patients (p=0.06). In female patients IBS subtypes were as follows; IBS mixed type (IBS-M) 37% (n=12), IBS diarrhea predominant (IBS-D) 22% (n=7), IBS unsubtyped (IBS-U) 22% (n=7), and IBS constipation predominant (IBS-C) 19% (n=6), whereas in male patients, IBS-M 57% (n=8), IBS-C 29% (n=4), IBS-D 7% (n=1) and IBS-U 7% (n=1). The most common subtype of IBS was IBS-M in both sexes. Conclusion: IBS is frequent in FMF patients when Rome III criteria are used for diagnosis. The question to be answered is whether increased frequency or merely the failure of Rome III criteria to differentiate IBS in such patient groups with abdominal discomfort.

UR - http://www.scopus.com/inward/record.url?scp=84944274748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944274748&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 841

EP - 846

JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

SN - 1520-4391

IS - 4

ER -